Fidelity Investments
ENZ

Fidelity Investments’s Enzo Biochem, Inc. ENZ Stock Holding History

Fidelity Investments’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-429
Closed -$159 – 5555
2025
Q1 		$159 Sell
429
-126
-23% -$70 ﹤0.01% 5091
2024
Q4 		$396 Buy
555
+126
+29% +$131 ﹤0.01% 5008
2024
Q3 		$480 Hold
429
– – ﹤0.01% 4973
2024
Q2 		$468 Sell
429
-1,556
-78% -$1.75K ﹤0.01% 4871
2024
Q1 		$2.52K Buy
1,985
+1,555
+362% +$2.05K ﹤0.01% 4654
2023
Q4 		$597 Buy
430
+130
+43% +$172 ﹤0.01% 4802
2023
Q3 		$420 Buy
+300
New +$452 ﹤0.01% 4730
2023
Q1 		– Sell
-518
Closed -$741 – 5576
2022
Q4 		$741 Hold
518
– – ﹤0.01% 4694
2022
Q3 		$1K Hold
518
– – ﹤0.01% 4763
2022
Q2 		$1K Hold
518
– – ﹤0.01% 4827
2022
Q1 		$2K Buy
+518
New +$1.66K ﹤0.01% 4726
2018
Q4 		– Sell
-1
Closed – – 4257
2018
Q3 		$0 Buy
+1
New +$5 ﹤0.01% 3836

Other funds holding ENZ

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

Fidelity Investments's ENZ Position: Q2 2025 in Review

Fidelity Investments sold out of Enzo Biochem, Inc. (ENZ) in Q2 2025, closing a stake of 429 shares — an estimated $159 sold.

Fidelity Investments first reported a position in ENZ in Q3 2018 and held it in 12 quarters. The position peaked at $2.52K in Q1 2024. 6 funds tracked by Wall St. Rank hold ENZ as of Q2 2025.

  • Fidelity Investments reported no remaining Enzo Biochem, Inc. position as of Q2 2025 after selling out during the quarter.
  • Fidelity Investments sold 429 Enzo Biochem, Inc. shares in Q2 2025, an estimated $159.
  • Fidelity Investments first reported a position in Enzo Biochem, Inc. in Q3 2018 and held it in 12 quarters.
  • Fidelity Investments's Enzo Biochem, Inc. position peaked at $2.52K in Q1 2024.
  • 6 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2025.

Based on Fidelity Investments's 13F filing for Q2 2025, filed 14 Aug 2025.